GPCR - Structure Therapeutics Inc.
Structure Therapeutics Inc. , an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R).
As of Oct 13, 2026: spot at $22.44, ATM IV 409.8%, max pain $27.50, net GEX $28.8K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $1.28B
- Beta
- -1.52
- 52-Week Range
- 22.15-94.9
- CEO
- Raymond C. Stevens
- Employees
- 281
- IPO Date
- Feb 3, 2023
- Exchange
- NASDAQ
What GPCR Looks Like to Options Traders Today
IV rank of 96.7% signals elevated pricing relative to the 1-year history, conditions that typically favor premium-selling structures (credit spreads, iron condors, covered calls); positive net gamma exposure ($28.8K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.262) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The GPCR overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked GPCR overview questions
- What is GPCR?
- GPCR is the ticker symbol for Structure Therapeutics Inc., a listed security. Structure Therapeutics Inc. , an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. Listed on NASDAQ. GPCR is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the GPCR options snapshot look like today?
- As of Oct 13, 2026, the GPCR options snapshot shows spot at $22.44, ATM IV 409.8%, IV rank 96.7%, max pain $27.50, net GEX $28.8K, expected move 117.49%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are GPCR's key statistics?
- Structure Therapeutics Inc. (GPCR) carries a market capitalization of $1.28B, beta of -1.52 relative to the broader market, 52-week range of 22.15-94.9. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does GPCR belong to?
- Structure Therapeutics Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare GPCR's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the GPCR data on this page?
- The options snapshot above is dated Oct 13, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, twice-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).